Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Rafael Holdings Inc (NY: RFL ) 1.420 -0.030 (-2.07%) Official Closing Price Updated: 7:00 PM EDT, Jul 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Rafael Holdings Inc Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results June 14, 2024 Strategically focused on generating shareholder value by advancing our portfolio and identifying attractive investment opportunities with substantive upside potential From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1 May 30, 2024 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results March 13, 2024 From Rafael Holdings, Inc. Via GlobeNewswire Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results December 14, 2023 Company remains focused on generating shareholder value by advancing our portfolio and identifying attractive opportunities for strategic investments From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Reports Third Quarter 2023 Financial Results November 15, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results October 30, 2023 Company positions itself to generate value for its stockholders by curtailing expenses while increasing investment in strategic opportunities From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Reports Second Quarter 2023 Financial Results August 15, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc. August 02, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Reports Third Quarter Fiscal 2023 Financial Results and Provides Business Update June 13, 2023 Since the end of the third quarter, we made an initial $2.1 million investment in Cyclo Therapeutics, Inc. (Nasdaq: CYTH) and have an agreement to increase our investment by $5 million From Rafael Holdings, Inc. Via GlobeNewswire Cyclo Therapeutics Announces Execution of Definitive Agreement with Rafael Holdings, Inc. Providing for $5.0 Million of Additional Funding Via a Private Placement June 05, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results May 15, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Cyclo Therapeutics Announces Closing of Strategic Investment Through a $2.1 Million Private Placement from Rafael Holdings, Inc. (NYSE:RFL) May 02, 2023 From Cyclo Therapeutics, Inc. Via Business Wire Rafael Holdings Announces up to $5 Million Share Repurchase Program April 04, 2023 Announces expanded search for strategic opportunities beyond biopharma From Rafael Holdings, Inc. Via GlobeNewswire Rafael Holdings Reports Second Quarter Fiscal 2023 Financial Results March 14, 2023 From Rafael Holdings, Inc. Via GlobeNewswire Rafael Holdings Reports First Quarter Fiscal 2023 Financial Results December 13, 2022 From Rafael Holdings, Inc. Via GlobeNewswire Rafael Holdings to Focus on Strategic Business Development Initiatives and Curtail Early Stage Development Activities November 15, 2022 From Rafael Holdings, Inc. Via GlobeNewswire Rafael Holdings Reports Fourth Quarter Fiscal 2022 Financial Results October 31, 2022 From Rafael Holdings, Inc. Via GlobeNewswire Cornerstone Pharmaceuticals Initiates Phase 1 Trial of CPI-613® (devimistat) in Combination with Chemoradiation for the Treatment of Advanced Pancreatic Cancer September 28, 2022 Clinical program advancement represents key milestone for Cornerstone underscoring its commitment to the development of lead compound, devimistat, in pancreatic cancer From Cornerstone Pharmaceuticals Via GlobeNewswire SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates RFL, SAFM, SNR; Shareholders are Encouraged to Contact the Firm September 01, 2021 NEW YORK, NY / ACCESSWIRE / September 1, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Rafael Holdings, Inc. (NYSE:RFL) concerning... From Halper Sadeh LLP Via AccessWire Topics Fraud Exposures Legal RAFAEL (RFL) STOCKHOLDER ALERT - Andrews & Springer LLC Is Seeking More Cash for Shareholders of Rafael Holdings, Inc. August 16, 2021 From Andrews & Springer LLC Via Business Wire RAFAEL HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Rafael Holdings, Inc. - RFL June 24, 2021 From Kahn Swick & Foti, LLC Via Business Wire Rafael Holdings Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Rafael Holdings, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – RFL June 21, 2021 From Halper Sadeh LLP Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.